Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 458 JPY 2.46% Market Closed
Market Cap: 35.4B JPY
Have any thoughts about
Fuji Pharma Co Ltd?
Write Note

Fuji Pharma Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fuji Pharma Co Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Fuji Pharma Co Ltd
TSE:4554
Other Long-Term Assets
ÂĄ6.8B
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
26%
Takeda Pharmaceutical Co Ltd
TSE:4502
Other Long-Term Assets
ÂĄ423.3B
CAGR 3-Years
-1%
CAGR 5-Years
12%
CAGR 10-Years
6%
Daiichi Sankyo Co Ltd
TSE:4568
Other Long-Term Assets
ÂĄ476.6B
CAGR 3-Years
41%
CAGR 5-Years
36%
CAGR 10-Years
12%
Otsuka Holdings Co Ltd
TSE:4578
Other Long-Term Assets
ÂĄ179.6B
CAGR 3-Years
45%
CAGR 5-Years
34%
CAGR 10-Years
15%
Chugai Pharmaceutical Co Ltd
TSE:4519
Other Long-Term Assets
ÂĄ129.9B
CAGR 3-Years
18%
CAGR 5-Years
13%
CAGR 10-Years
13%
Astellas Pharma Inc
TSE:4503
Other Long-Term Assets
ÂĄ83.4B
CAGR 3-Years
9%
CAGR 5-Years
-4%
CAGR 10-Years
3%
No Stocks Found

Fuji Pharma Co Ltd
Glance View

Market Cap
35.4B JPY
Industry
Pharmaceuticals

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Intrinsic Value
2 002.38 JPY
Undervaluation 27%
Intrinsic Value
Price

See Also

What is Fuji Pharma Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
6.8B JPY

Based on the financial report for Jun 30, 2024, Fuji Pharma Co Ltd's Other Long-Term Assets amounts to 6.8B JPY.

What is Fuji Pharma Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
26%

Over the last year, the Other Long-Term Assets growth was 47%. The average annual Other Long-Term Assets growth rates for Fuji Pharma Co Ltd have been 15% over the past three years , 11% over the past five years , and 26% over the past ten years .

Back to Top